Edition:
avatar image
Advertisement

HKSTP and Roche forge strategic collaboration to spur life science innovation and build hub

  • Hong Kong Science and Technology Parks (HKSTP) and global pharmaceutical and diagnostic giant Roche join hands to promote life science innovation.
  • The goal is to build an enhanced platform supporting biomedical innovation startups and develop the Greater Bay Area (GBA) into a life science hub.

Paid Post:Roche Hong Kong
Reading Time:4 minutes
Why you can trust SCMP
Inking the deal: HKSTP and Roche signed the Collaboration Agreement in January 2023.

[The content of this article has been produced by our advertising partner.]

Under the Collaboration Agreement, HKSTP and Roche will work closely together and leverage their established ecosystems to advance life science development by focusing on several key areas, including policy shaping, startup co-incubation in Hong Kong and overseas, and health data sharing.

HKSTP and Roche aim to share ideas and suggestions to help optimise policy in Hong Kong to facilitate life science and biomedical innovation, thereby transforming the city into one of the hubs for GBA and Asia Pacific (APAC) in terms of innovation adoption and treatment registration.

The hub development will be supported by an enhanced co-incubation platform and ecosystem nurturing startups from Hong Kong and overseas in the specialised areas ranging from research and clinical trials to innovation commercialisation, as well as by a network connecting startups with their potential partners. GBA will elevate its status to become one of the APAC centres for innovation and technology talent and corporations.

Through the exchanges and collaboration of all stakeholders, an optimised health data-sharing environment will be built in the HKSTP platform. It will help explore the development of synthetic data generation tools and promote the ‘data collaboration’ concept in the community.

From left, APAC Sub Region 3 Head, Roche Diagnostics Asia Pacific, Agnes Ho; Head of Institute for Translational Research, HKSTP, Dr Grace Lau; and Area Head, Asia Pacific, Roche Pharmaceuticals, Dr Ahmed Elhusseiny.
From left, APAC Sub Region 3 Head, Roche Diagnostics Asia Pacific, Agnes Ho; Head of Institute for Translational Research, HKSTP, Dr Grace Lau; and Area Head, Asia Pacific, Roche Pharmaceuticals, Dr Ahmed Elhusseiny.
Advertisement